Učitavanje...
Emerging biomarkers in the diagnosis of prostate cancer
Prostate cancer (PCa) is the second most common cancer in men worldwide. A large proportion of PCa are latent, never destined to progress or affect the patients’ life. It is of utmost importance to identify which PCa are destined to progress and which would benefit from an early radical treatment. P...
Spremljeno u:
| Izdano u: | Pharmgenomics Pers Med |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5961643/ https://ncbi.nlm.nih.gov/pubmed/29844697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S136026 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|